Gedatolisib-Based Regimens May Advance PIK3CA Wild-Type Metastatic Breast Cancer Care

1 month ago 22

Sara A. Hurvitz, MD, FACP, discusses the design of VIKTORIA-1, key efficacy and safety findings, and how these data may influence breast cancer management.

1. Homepage
2. Breast Cancer
3. Gedatolisib-Based Regimens May Advance PIK3CA Wild-Type Metastatic Breast Cancer Care